For companies

​With a solid foundation in pharmacology, statistics and pharmacoepidemiology the Phase4CPH team is ready to solve real world evidence related challenges for your company.

Among others, we engage in:

• Public-private partnerships
• Health authority-initiated studies
• Post-authorization safety (PASS) and effectiveness studies (PAES)
• Comparative effectiveness research (CER)
• Real world evidence on drug effects, safety and utilization
• Potential new indications for established drugs

Phase4CPh is registered in ENCePP’s HMA-EMA Catalogues of real-world data sources and studies  (https://catalogues.ema.europa.eu/in​stitution/49802).

Please contact us for more information about Phase4CPH and future collaboration:

Send an email to Janne Petersen 

Administration: Send an e-mail  to Diana Kali